References
Hoffmann GF, Charpentier C, Mayatepek E et al (1993) Clinical and biochemical phenotype in eleven patients with mevalonic aciduria.Pediatrics 91: 915–921.
Huber M, Müller J, Leier I et al (1990) Metabolism of cysteinyl leukotrienes in monkey and man.Eur J Biochem 194: 309–315.
Jedlitschky G, Huber M, Völkl A et al (1991) Peroxisomal degradation of leukotrienes by β-oxidation from the θ-end.J Biol Chem 266: 24763–24772.
Keppler D, Huber M, Hagmann W et al (1988) Metabolism and analysis of endogenous cysteinyl leukotrienes.Ann NY Acad Sci 524: 68–74.
Mayatepek E, Lehmann W-D, Fauler J et al (1993a) Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.J Clin Invest 91: 881–888.
Mayatepek E, Hoffmann GF, Bremer HJ (1993b) Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency.J Pediatr 123: 96–98.
Samuelsson B, Dahlén S-E, Lindgren JA et al (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.Science (Washington DC) 237: 1171–1176.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayatepek, E., Hoffmann, G.F. Impaired metabolism of leukotrienes in inherited metabolic disorders. J Inherit Metab Dis 17, 263–266 (1994). https://doi.org/10.1007/BF00711803
Issue Date:
DOI: https://doi.org/10.1007/BF00711803